Genetic dissection and functional studies in Hirschsprung disease
PhD ceremony: Ms. Y. Sribudiani, 14.30 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: Genetic dissection and functional studies in Hirschsprung disease
Promotor(s): prof. R.M.W. Hofstra
Faculty: Medical Sciences
Hirschsprung disease (HSCR) is a congenital neurological condition of the colon. Patients with HSCR have severe and sometimes even life-threatening constipation. This is due to a lack of ganglia that regulate the normal peristaltic movement of the colon. HSCR is considered to be a genetic disorder and 12 genes have now been identified. However, mutations in these genes explain only some of the HSCR patients. The research in this thesis focused on a better understanding of the nervous system of the colon (the enteric nervous system or ENS) and on finding and characterizing mutations and genes that contribute to disease development. To gain a better insight into the normal development of the ENS, progenitor cells of the ENS from embryonic mouse guts were isolated. The expression profiles of the cells were analyzed and compared with the expression profile of the entire gut. This resulted in a list of genes that are essential for ENS development and are perfect candidate genes for HSCR. Genes in regions previously identified as containing an HSCR gene were also studied. This resulted in one new HSCR gene, which proved to be associated specifically in the Chinese patient population. Finally, the function of a previously identified common mutation that is present in ~70% of HSCR patients was characterized.
Last modified: | 13 March 2020 01.11 a.m. |
More news
-
16 January 2025
€16,5 miljoen subsidie voor onderzoek naar effect CAR T-cellen bij terugkerende beenmergkanker
Het UMCG gaat specifieke CAR-T cellen produceren om patiënten met terugkerende beenmergkanker te behandelen. Samen met Amsterdam UMC Cancer Center Amsterdam gaat het UMCG de effectiviteit van deze mogelijk nieuwe behandeling onderzoeken. Voor het...
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. Jouke de Vries, the chair of the Executive Board, looks back.
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...